propranolol has been researched along with Kidney Failure, Chronic in 71 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Minoxidil has been administered to 16 patients with severe hypertension and renal failure." | 9.04 | Minoxidil in severe hypertension. ( Mäkelä, M; Oka, M, 1978) |
| "The effect of propranolol on renal haemodynamics was studied in nine patients with arterial hypertension and moderate to severe chronic renal failure." | 7.67 | Renal haemodynamics during propranolol treatment in patients with arterial hypertension and chronic renal failure. ( Fjeldborg, P; Jacobsen, BA, 1986) |
| "We describe the occurrence of hyperkalemia in a stable hemodialysis patient who developed digoxin toxicity." | 7.67 | Hyperkalemia complicating digoxin toxicity in a patient with renal failure. ( Fraser, C; Papadakis, MA; Sedlacek, SM; Wexman, MP, 1985) |
| "To assess the importance of disease-induced increases in plasma concentrations of alpha1 acid glycoprotein (an acute-phase plasma protein that binds cationic drugs), we determined binding of propranolol in plasma from 53 patients and 25 healthy volunteers." | 7.66 | Increased plasma protein binding of propranolol and chlorpromazine mediated by disease-induced elevations of plasma alpha1 acid glycoprotein. ( Borgá, O; Johansson, C; Odar-Cederlöf, I; Piafsky, KM; Sjöqvist, F, 1978) |
| "The incidence of bone resorption evaluated on X-ray findings and on bone biopsy specimens was of a comparable degree in the two groups." | 5.26 | Effect of chronic propranolol treatment on bone changes of secondary hyperparathyroidism in dialysis patients. ( Ballanti, P; Bonucci, E; Ciccarelli, C; Maggiore, Q; Pizzarelli, F; Zoccali, C, 1982) |
| "Penbutolol and propranolol were administered orally in a dosage of 40 mg once daily and 80 mg twice daily, respectively to 12 patients with hypertension and impaired renal function." | 5.06 | Comparison of the effects of penbutolol and propranolol on glomerular filtration rate in hypertensive patients with impaired renal function. ( Donker, AJ; Heidendal, GA; Oe, PL; Reijn, E; van der Meulen, J, 1986) |
| "Minoxidil has been administered to 16 patients with severe hypertension and renal failure." | 5.04 | Minoxidil in severe hypertension. ( Mäkelä, M; Oka, M, 1978) |
| "Nonselective β-blockers (NSBBs), such as propranolol, reportedly exert a pleiotropic effect in liver cirrhosis." | 3.78 | Is there any vindication for low dose nonselective β-blocker medication in patients with liver cirrhosis? ( Cho, YK; Chon, CU; Jeon, WK; Kim, BI; Kim, HJ; Kim, TW; Park, DI; Park, JH; Sohn, CI; Won, HS, 2012) |
| "The effect of chronic renal disease on the serum free fraction of phenytoin, diazepam and propranolol was examined in vitro among 60 conservatively treated patients with renal insufficiency of varying degree and different etiology, and in 10 patients with a nephrotic syndrome." | 3.67 | Serum protein binding of phenytoin, diazepam and propranolol in chronic renal diseases. ( Neuvonen, PJ; Tallgren, LG; Tiula, E, 1987) |
| "The effect of propranolol on renal haemodynamics was studied in nine patients with arterial hypertension and moderate to severe chronic renal failure." | 3.67 | Renal haemodynamics during propranolol treatment in patients with arterial hypertension and chronic renal failure. ( Fjeldborg, P; Jacobsen, BA, 1986) |
| "We describe the occurrence of hyperkalemia in a stable hemodialysis patient who developed digoxin toxicity." | 3.67 | Hyperkalemia complicating digoxin toxicity in a patient with renal failure. ( Fraser, C; Papadakis, MA; Sedlacek, SM; Wexman, MP, 1985) |
| "To assess the importance of disease-induced increases in plasma concentrations of alpha1 acid glycoprotein (an acute-phase plasma protein that binds cationic drugs), we determined binding of propranolol in plasma from 53 patients and 25 healthy volunteers." | 3.66 | Increased plasma protein binding of propranolol and chlorpromazine mediated by disease-induced elevations of plasma alpha1 acid glycoprotein. ( Borgá, O; Johansson, C; Odar-Cederlöf, I; Piafsky, KM; Sjöqvist, F, 1978) |
| "Propranolol was administered before hemodialysis treatment, after 40 minutes supine resting period." | 2.71 | Effect of propranolol on heart rate variability in patients with end-stage renal disease: a double-blind, placebo-controlled, randomized crossover pilot trial. ( Berta, K; Fekete, A; Horváth, E; Reusz, GS; Sallay, P; Süveges, Z; Szabó, AJ; Szabó, T; Tory, K; Tulassay, T, 2004) |
| "Propranolol and enalapril were ineffective antihypertensive agents in most cats of this study." | 2.68 | Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease. ( Armstrong, J; Brownfield, M; Henik, RA; Jensen, J, 1997) |
| " The half-life of total radioactivity is greatly lengthened in the presence of severe renal failure while the half-lives of the pharmacologically active propranolol and 4-hydroxymetabolite are slightly reduced." | 2.64 | Pharmacodynamics of propranolol in renal failure. ( Foulkes, DM; Joekes, AM; Thompson, FD, 1972) |
| "The chronic renal failure was induced by surgical ablation of 75% renal mass." | 1.28 | [Effects of alpha and beta receptor blockaders on urinary excretion of sodium and potassium in healthy rats and in those with chronic renal failure]. ( Jakubowski, Z; Manitius, A; Manitius, J, 1992) |
| " Pharmacokinetic variable values in elderly subjects did not differ in a clinically significant manner from those in younger subjects." | 1.28 | Pharmacokinetics of misoprostol in the elderly, in patients with renal failure and when coadministered with NSAID or antipyrine, propranolol or diazepam. ( Karim, A; Nicholson, PA; Smith, M, 1990) |
| "Captopril was also able to reduce the proteinuria of non-diabetic glomerular origin." | 1.28 | Effects of angiotensin converting enzyme inhibitors on the progression of renal failure and proteinuria in humans. ( Alcazar, JM; Gutierrez-Millet, V; Oliet, A; Praga, M; Rodicio, JL; Ruilope, LM, 1989) |
| "Tertatolol is a new beta-blocking agent which induces renal vasodilation in experimental animals and humans and increases glomerular filtration rate (GFR), diuresis and natriuresis." | 1.27 | Tertatolol ameliorates renal function in rats with chronic renal failure. ( Delaini, F; Garattini, S; Lupini, C; Patino, O; Perico, N; Remuzzi, G; Tagliaferri, M, 1988) |
| "The incidence of bone resorption evaluated on X-ray findings and on bone biopsy specimens was of a comparable degree in the two groups." | 1.26 | Effect of chronic propranolol treatment on bone changes of secondary hyperparathyroidism in dialysis patients. ( Ballanti, P; Bonucci, E; Ciccarelli, C; Maggiore, Q; Pizzarelli, F; Zoccali, C, 1982) |
| "In 11 patients with chronic renal failure serum 3'-T1 levels were highly increased 285 pmol/l (115 - 1538 pmol/l) (P less than 0." | 1.26 | Serum 3'-monoiodothyronine levels in normal subjects and in patients with thyroid and non-thyroid disease. ( Cohn, D; Faber, J; Friis, T; Kirkegaard, C; Kølendorf, K; Lumholtz, IB; Siersbaek-Nielsen, K; Thomsen, HF, 1981) |
| " 6 There is, therefore, no pharmacokinetic basis to adjust the dosage of propranolol in patients with renal failure." | 1.26 | Propranolol disposition in renal failure. ( Shand, DG; Spannuth, CL; Stone, WJ; Vestal, RE; Wilkinson, GR; Wood, AJ, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 58 (81.69) | 18.7374 |
| 1990's | 10 (14.08) | 18.2507 |
| 2000's | 1 (1.41) | 29.6817 |
| 2010's | 1 (1.41) | 24.3611 |
| 2020's | 1 (1.41) | 2.80 |
| Authors | Studies |
|---|---|
| Zhou, H | 1 |
| Sim, JJ | 1 |
| Shi, J | 1 |
| Shaw, SF | 1 |
| Lee, MS | 1 |
| Neyer, JR | 1 |
| Kovesdy, CP | 1 |
| Kalantar-Zadeh, K | 1 |
| Jacobsen, SJ | 1 |
| Kim, TW | 1 |
| Kim, HJ | 1 |
| Chon, CU | 1 |
| Won, HS | 1 |
| Park, JH | 1 |
| Park, DI | 1 |
| Cho, YK | 1 |
| Sohn, CI | 1 |
| Jeon, WK | 1 |
| Kim, BI | 1 |
| Tory, K | 1 |
| Horváth, E | 1 |
| Süveges, Z | 1 |
| Fekete, A | 1 |
| Sallay, P | 1 |
| Berta, K | 1 |
| Szabó, T | 1 |
| Szabó, AJ | 1 |
| Tulassay, T | 1 |
| Reusz, GS | 1 |
| Kukreja, SC | 1 |
| Williams, GA | 1 |
| Vora, NM | 1 |
| Hargis, GK | 1 |
| Martinez Vea, A | 2 |
| Montoliu, J | 2 |
| Andreu, L | 2 |
| Torras, A | 1 |
| Gaya, J | 1 |
| López-Pedret, J | 1 |
| Revert, L | 2 |
| Balant, LP | 1 |
| Dayer, P | 1 |
| Fabre, J | 1 |
| Brunner, HR | 1 |
| Gavras, H | 1 |
| Waeber, B | 1 |
| Arrizabalaga, P | 1 |
| López Pedret, J | 1 |
| Kawasaki, T | 1 |
| Ueno, M | 1 |
| Uezono, K | 1 |
| Abe, I | 1 |
| Kawazoe, N | 1 |
| Omae, T | 3 |
| Nakamura, S | 1 |
| Cooper, RG | 1 |
| Stafford, LE | 1 |
| Belsey, R | 1 |
| Mueggler, P | 1 |
| Swanson, JR | 1 |
| Meltzer, VN | 1 |
| Goldberg, AP | 2 |
| Tindira, CA | 1 |
| Naumovich, AD | 1 |
| Harter, HR | 2 |
| Parrott, KA | 1 |
| Maeda, T | 1 |
| Onoyama, K | 1 |
| Fujimi, S | 1 |
| Pérez-García, R | 1 |
| Jofre, R | 1 |
| Vasconez, F | 1 |
| Caballero, A | 1 |
| Valderrábano, F | 1 |
| Pizzarelli, F | 1 |
| Zoccali, C | 1 |
| Ciccarelli, C | 1 |
| Maggiore, Q | 1 |
| Bonucci, E | 1 |
| Ballanti, P | 1 |
| Besarab, A | 2 |
| Caro, JF | 2 |
| Ihle, BU | 1 |
| Burke, JF | 2 |
| Glennon, JA | 2 |
| Fischer, JA | 1 |
| Kirkegaard, C | 1 |
| Faber, J | 1 |
| Cohn, D | 1 |
| Kølendorf, K | 1 |
| Thomsen, HF | 1 |
| Lumholtz, IB | 1 |
| Siersbaek-Nielsen, K | 1 |
| Friis, T | 1 |
| Hagberg, J | 1 |
| Delmez, JA | 1 |
| Carney, RM | 1 |
| McKevitt, PM | 1 |
| Ehsani, AA | 1 |
| Farrington, K | 1 |
| Hamzeh, J | 1 |
| Varghese, Z | 1 |
| Moorhead, JF | 1 |
| Zeis, PM | 1 |
| Thanopoulos, B | 1 |
| Pierroutsakos, IN | 1 |
| Koukoutsakis, PM | 1 |
| Wood, AJ | 1 |
| Vestal, RE | 1 |
| Spannuth, CL | 1 |
| Stone, WJ | 1 |
| Wilkinson, GR | 1 |
| Shand, DG | 1 |
| Wagner, R | 1 |
| von Hundelshausen, B | 1 |
| Tempel, G | 1 |
| Schneck, HJ | 1 |
| Pichlmeier, R | 1 |
| Hipp, R | 1 |
| Allon, M | 3 |
| Takeshian, A | 1 |
| Shanklin, N | 3 |
| Dansby, L | 1 |
| Jensen, J | 1 |
| Henik, RA | 1 |
| Brownfield, M | 1 |
| Armstrong, J | 1 |
| Van den Branden, C | 1 |
| Gabriels, M | 1 |
| Vamecq, J | 1 |
| Vanden Houte, K | 1 |
| Verbeelen, D | 1 |
| Ohnhaus, EE | 1 |
| Bouvenot, G | 1 |
| Escande, M | 1 |
| Jouve, R | 1 |
| Delboy, C | 1 |
| Oka, M | 1 |
| Mäkelä, M | 1 |
| Fillastre, JP | 1 |
| Godin, M | 1 |
| Guédon, J | 1 |
| Aubert, P | 1 |
| Lucsko, M | 1 |
| Chaignon, M | 1 |
| Dugrais, G | 1 |
| Winnock, S | 1 |
| Castagne, A | 1 |
| Bonnet, A | 1 |
| Torrielli, R | 1 |
| Janvier, G | 1 |
| Moore, SB | 1 |
| Goodwin, FJ | 1 |
| Jensen, HA | 1 |
| Bjaeldager, P | 1 |
| Broch-Moller, B | 1 |
| Piafsky, KM | 1 |
| Borgá, O | 1 |
| Odar-Cederlöf, I | 1 |
| Johansson, C | 1 |
| Sjöqvist, F | 1 |
| Kanis, JA | 1 |
| Adams, ND | 1 |
| Cecchettin, M | 2 |
| Luizetto, G | 1 |
| Gaspar, S | 2 |
| Heynen, G | 2 |
| Kanis, J | 1 |
| Franchimont, P | 1 |
| Hepp, A | 1 |
| Maisch, B | 1 |
| Raff, U | 1 |
| Hayduk, K | 1 |
| Mutterperl, RE | 1 |
| Diamond, FB | 1 |
| Lowenthal, DT | 3 |
| Curtis, JR | 1 |
| Bateman, FJ | 1 |
| Warren, DJ | 2 |
| De Sancho, JL | 1 |
| Muñíz, R | 1 |
| Gómez-Ullate, P | 1 |
| Orofino, L | 1 |
| Villar, F | 1 |
| Lampreabe, I | 1 |
| García Damborenea, R | 1 |
| Shapiro, B | 1 |
| Kollmann, GJ | 1 |
| Heine, WI | 1 |
| Fine, RN | 1 |
| Yadin, O | 1 |
| Moulten, L | 1 |
| Nelson, PA | 1 |
| Boechat, MI | 1 |
| Lippe, BH | 1 |
| Manitius, J | 1 |
| Jakubowski, Z | 1 |
| Manitius, A | 1 |
| Nicholson, PA | 1 |
| Karim, A | 1 |
| Smith, M | 1 |
| Rodicio, JL | 2 |
| Alcazar, JM | 2 |
| Ruilope, LM | 2 |
| Praga, M | 1 |
| Oliet, A | 1 |
| Gutierrez-Millet, V | 1 |
| Yang, WC | 1 |
| Huang, TP | 1 |
| Ho, LT | 1 |
| Chung, HM | 1 |
| Chan, YL | 1 |
| Batlle, DC | 1 |
| Delaini, F | 1 |
| Perico, N | 1 |
| Tagliaferri, M | 1 |
| Lupini, C | 1 |
| Patino, O | 1 |
| Remuzzi, G | 1 |
| Garattini, S | 1 |
| Vanholder, R | 1 |
| Lamiere, N | 1 |
| Ringoir, S | 1 |
| Wells, TG | 1 |
| Ulstrom, RA | 1 |
| Nevins, TE | 1 |
| Castellino, P | 1 |
| Bia, M | 1 |
| DeFronzo, RA | 1 |
| Tiula, E | 1 |
| Tallgren, LG | 1 |
| Neuvonen, PJ | 1 |
| van der Meulen, J | 1 |
| Reijn, E | 1 |
| Heidendal, GA | 1 |
| Oe, PL | 1 |
| Donker, AJ | 1 |
| Radin, MJ | 1 |
| Wilke, WL | 1 |
| Fettman, MJ | 1 |
| Jacobsen, BA | 1 |
| Fjeldborg, P | 1 |
| Ho, KY | 1 |
| Evans, WS | 1 |
| Thorner, MO | 1 |
| Andermann, E | 1 |
| Andermann, F | 1 |
| Carpenter, S | 1 |
| Wolfe, LS | 1 |
| Nelson, R | 1 |
| Patry, G | 1 |
| Boileau, J | 1 |
| Papadakis, MA | 1 |
| Wexman, MP | 1 |
| Fraser, C | 1 |
| Sedlacek, SM | 1 |
| Briggs, WA | 1 |
| Gibson, TP | 1 |
| Nelson, H | 1 |
| Cirksena, WJ | 1 |
| Kennedy, AC | 1 |
| Siegler, RL | 1 |
| Swainson, CP | 1 |
| Wright, N | 1 |
| Cranston, WI | 1 |
| Thompson, FD | 1 |
| Joekes, AM | 1 |
| Foulkes, DM | 1 |
| Franzen, P | 1 |
| Pasternack, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Viscous Fiber on Postprandial Kalemic Response in Hemodialysis Patients[NCT05086185] | 20 participants (Anticipated) | Observational | 2021-06-29 | Enrolling by invitation | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
7 reviews available for propranolol and Kidney Failure, Chronic
| Article | Year |
|---|---|
Consequences of renal insufficiency on the hepatic clearance of some drugs.
Topics: Adrenergic beta-Antagonists; Biotransformation; Dextropropoxyphene; Ethanolamines; Humans; Kidney Di | 1983 |
[Long-term dialysis and its problems: hypertension].
Topics: Humans; Hydralazine; Hypertension, Renal; Japan; Kidney Failure, Chronic; Propranolol; Renal Dialysi | 1980 |
[Dosage of digitalis glycosides and beta blockers in renal insufficiency].
Topics: Adrenergic beta-Antagonists; Creatinine; Digitalis Glycosides; Digoxin; Humans; Kidney Failure, Chro | 1976 |
[Renal hypertension (author's transl)].
Topics: Adult; Angiotensin II; Animals; Female; Humans; Hypertension, Renal; Kidney Failure, Chronic; Kidney | 1978 |
Therapeutic effect and complication profile of clonidine-beta-blocker combinations.
Topics: Adrenergic beta-Antagonists; Cardiovascular Diseases; Clonidine; Drug Combinations; Humans; Hyperten | 1988 |
Disorders of prolactin and growth hormone secretion.
Topics: Acromegaly; Arginine; Clonidine; Dwarfism; Female; Glucose Tolerance Test; Growth Hormone; Growth Ho | 1985 |
Advances in medicine.
Topics: Acute Kidney Injury; Asthma; Blindness; Catecholamines; Contraceptives, Oral; Coronary Disease; Guan | 1968 |
16 trials available for propranolol and Kidney Failure, Chronic
| Article | Year |
|---|---|
Effect of propranolol on heart rate variability in patients with end-stage renal disease: a double-blind, placebo-controlled, randomized crossover pilot trial.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Child; Cross-Over Studies; Dopamine; Double-Blind Me | 2004 |
[Prospective study of the effect of propanolol on Ca-P metabolism in chronic renal insufficiency].
Topics: Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Hyperparathyroidism, Secondary; K | 1982 |
Effect of insulin-plus-glucose infusion with or without epinephrine on fasting hyperkalemia.
Topics: Adult; Blood Glucose; Epinephrine; Fasting; Female; Glucose; Humans; Hyperkalemia; Infusions, Intrav | 1993 |
Glucose modulation of the disposal of an acute potassium load in patients with end-stage renal disease.
Topics: Adult; Analysis of Variance; Blood Glucose; Female; Glucose; Humans; Hyperkalemia; Insulin; Kidney F | 1993 |
Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease.
Topics: Adrenergic beta-Antagonists; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; | 1997 |
Minoxidil in severe hypertension.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Cardiac Output; Cardiomegaly; Clinical Trials as Top | 1978 |
Letter: Hypoglycaemia in propranolol-treated dialysis patients.
Topics: Blood Glucose; Drug Evaluation; Female; Humans; Hypertension; Hypoglycemia; Kidney Failure, Chronic; | 1976 |
A possible role for propranolol in the treatment of renal osteodystrophy.
Topics: Adolescent; Adult; Aged; Alkaline Phosphatase; Calcium; Chronic Kidney Disease-Mineral and Bone Diso | 1978 |
Long-term effects of minoxidil in the treatment of malignant hypertension in chronic renal failure.
Topics: Adolescent; Adult; Blood Pressure; Clinical Trials as Topic; Female; Heart Rate; Humans; Hypertensio | 1976 |
Use of prazosin in management of hypertension in patients with chronic renal failure and in renal transplant recipients.
Topics: Adult; Aged; Antihypertensive Agents; Chlorothiazide; Clinical Trials as Topic; Clonidine; Drug Eval | 1975 |
Extended recombinant human growth hormone treatment after renal transplantation in children.
Topics: Adolescent; Adrenal Cortex Hormones; Age Determination by Skeleton; Anthropometry; Child; Female; Gr | 1992 |
Influence of converting enzyme inhibition on glomerular filtration rate and proteinuria.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Captopril; Drug Therapy, Combination; Female; Furos | 1990 |
Therapeutic effect and complication profile of clonidine-beta-blocker combinations.
Topics: Adrenergic beta-Antagonists; Cardiovascular Diseases; Clonidine; Drug Combinations; Humans; Hyperten | 1988 |
Metabolic response to exercise in dialysis patients.
Topics: Adult; Blood Glucose; Blood Pressure; Catecholamines; Fatty Acids, Nonesterified; Female; Glucose; H | 1987 |
Comparison of the effects of penbutolol and propranolol on glomerular filtration rate in hypertensive patients with impaired renal function.
Topics: Blood Pressure; Clinical Trials as Topic; Creatinine; Double-Blind Method; Glomerular Filtration Rat | 1986 |
Pharmacodynamics of propranolol in renal failure.
Topics: Acute Kidney Injury; Administration, Oral; Adult; Blood Pressure; Carbon Isotopes; Creatinine; Feces | 1972 |
49 other studies available for propranolol and Kidney Failure, Chronic
| Article | Year |
|---|---|
β-Blocker Use and Risk of Mortality in Heart Failure Patients Initiating Maintenance Dialysis.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Atenolol; Bisoprolol; Carvedilol; Cause of Dea | 2021 |
Is there any vindication for low dose nonselective β-blocker medication in patients with liver cirrhosis?
Topics: Adrenergic beta-Antagonists; Adult; Aged; Alcohol Drinking; Carcinoma, Hepatocellular; Female; Follo | 2012 |
Normal responsiveness of serum parathyroid hormone to beta-adrenergic blockade in patients with secondary hyperparathyroidism.
Topics: Adrenergic beta-Antagonists; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Middle | 1981 |
Beta adrenergic modulation of extrarenal potassium disposal in terminal uraemia.
Topics: Adrenergic beta-Agonists; Adult; Aged; Epinephrine; Female; Humans; Hyperkalemia; Kidney Failure, Ch | 1983 |
Enhancement by diuretics of the antihypertensive action of long-term angiotensin converting enzyme blockade.
Topics: Adolescent; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Child; | 1980 |
Increase in serum potassium caused by beta-2 adrenergic blockade in terminal renal failure: absence of mediation by insulin or aldosterone.
Topics: Adult; Aged; Aldosterone; Atenolol; Female; Humans; Insulin; Kidney Failure, Chronic; Male; Middle A | 1983 |
Blood levels of long-acting propranolol in normal subjects and patients with renal failure.
Topics: Administration, Oral; Adult; Delayed-Action Preparations; Humans; Kidney Failure, Chronic; Kinetics; | 1983 |
Propranolol and spurious hyperbilirubinemia.
Topics: Adult; Bilirubin; Humans; Kidney Failure, Chronic; Male; Propranolol; Renal Dialysis | 1984 |
Effects of prazosin and propranolol on blood pressure and plasma lipids in patients undergoing chronic hemodialysis.
Topics: Adult; Blood Pressure; Cholesterol; Cholesterol, HDL; Female; Humans; Hypertension, Renal; Kidney Fa | 1984 |
Determination of propranolol in peritoneal dialysis fluid by high-performance liquid chromatography without extraction.
Topics: Ascitic Fluid; Chromatography, High Pressure Liquid; Humans; Kidney Failure, Chronic; Kinetics; Peri | 1983 |
Effect of chronic propranolol treatment on bone changes of secondary hyperparathyroidism in dialysis patients.
Topics: Bone Resorption; Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Hyperparathyroidism, Seco | 1982 |
Suppression of secondary hyperparathyroidism by propranolol in renal failure patients.
Topics: Alkaline Phosphatase; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Dihydrotachysterol; | 1981 |
Serum 3'-monoiodothyronine levels in normal subjects and in patients with thyroid and non-thyroid disease.
Topics: Adult; Depression; Female; Humans; Hyperthyroidism; Hypothyroidism; Kidney Failure, Chronic; Male; M | 1981 |
The metabolic and psychological effects of exercise training in hemodialysis patients.
Topics: Adult; Anemia; Blood Glucose; Blood Pressure; Carbohydrate Metabolism; Cholesterol; Female; Follow-U | 1980 |
Effects of oral propranolol on parathyroid hormone secretion in chronic renal failure.
Topics: Adolescent; Adult; Aged; Calcium; Child; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; | 1980 |
Complete atrioventricular block associated with propranolol therapy.
Topics: Child; Electrocardiography; Heart Block; Humans; Hypertension; Kidney Failure, Chronic; Male; Propra | 1981 |
Propranolol disposition in renal failure.
Topics: Administration, Oral; Blood Proteins; Humans; Kidney Failure, Chronic; Kinetics; Male; Mathematics; | 1980 |
[Left heart failure in anesthesia in a child pretreated with propranolol--case report].
Topics: Adolescent; Anesthesia, General; Catheters, Indwelling; Drug Therapy, Combination; Female; Heart Fai | 1994 |
Carvedilol protects against glomerulosclerosis in rat remnant kidney without general changes in antioxidant enzyme status. A comparative study of two beta-blocking drugs, carvedilol and propanolol.
Topics: Adrenergic beta-Antagonists; Aldehydes; Animals; Antioxidants; Blood Pressure; Carbazoles; Carvedilo | 1997 |
[Beta blockaders and general pathology].
Topics: Acebutolol; Adrenergic beta-Antagonists; Asthma; Female; Humans; Hypercalcemia; Hyperglycemia; Hypog | 1977 |
[Treatment by beta-blockers of arterial hypertension in patients with chronic renal insufficiency on hemodialysis].
Topics: Acebutolol; Adrenergic beta-Antagonists; Humans; Hypertension, Renal; Kidney Failure, Chronic; Pindo | 1978 |
[beta-blockers in hypertension with renal failure].
Topics: Acebutolol; Adrenergic beta-Antagonists; Adult; Atenolol; Diuretics; Drug Therapy, Combination; Fema | 1978 |
[General anesthesia in the hypertensive dialyzed renal failure patient treated with beta-blockers].
Topics: Adrenergic beta-Antagonists; Anesthesia, General; Humans; Hypertension; Kidney Failure, Chronic; Pro | 1979 |
Effect of beta-adrenergic blockade on plasma-renin activity and intractable hypertension in patients receiving regular dialysis treatment.
Topics: Adult; Blood Pressure; Depression, Chemical; Female; Humans; Hypertension, Malignant; Kidney Failure | 1976 |
Increased plasma protein binding of propranolol and chlorpromazine mediated by disease-induced elevations of plasma alpha1 acid glycoprotein.
Topics: Adult; Aged; alpha-Macroglobulins; Arthritis; Chlorpromazine; Crohn Disease; Disease; Female; Humans | 1978 |
Ethanol induced secretion of calcitonin in chronic renal disease.
Topics: Calcitonin; Calcium; Ethanol; Gastrins; Humans; Kidney Failure, Chronic; Parathyroid Hormone; Phosph | 1979 |
The effect of beta-blockade on ethanol-induced secretion of calcitonin in chronic renal failure.
Topics: Calcitonin; Calcium; Circadian Rhythm; Ethanol; Gastrins; Glomerular Filtration Rate; Humans; Insuli | 1977 |
[Comparative studies with propranolol, verapamil and atenolol in hypertensive dialysis patients].
Topics: Atenolol; Humans; Hypertension, Renal; Kidney Failure, Chronic; Propanolamines; Propranolol; Renal D | 1977 |
Beta-adrenergic receptor blockade and renal function.
Topics: Adult; Humans; Hypertension; Kidney; Kidney Failure, Chronic; Long-Term Care; Male; Oxprenolol; Prop | 1976 |
Pharmacokinetics of propranolol, quinidine, procainamide and lidocaine in chronic renal disease.
Topics: Biotransformation; Dose-Response Relationship, Drug; Humans; Kidney; Kidney Failure, Chronic; Lidoca | 1977 |
[Propranolol in the control of arterial hypertension in patients with chronic renal insufficiency].
Topics: Administration, Oral; Adult; Blood Pressure; Drug Evaluation; Humans; Hypertension, Renal; Kidney Fa | 1975 |
Pitfalls in the application of digoxin determinations.
Topics: Administration, Oral; Aged; Biopharmaceutics; Calcium; Digoxin; Drug Interactions; Female; Heart Dis | 1975 |
[Effects of alpha and beta receptor blockaders on urinary excretion of sodium and potassium in healthy rats and in those with chronic renal failure].
Topics: Animals; Disease Models, Animal; Glomerular Filtration Rate; Kidney Failure, Chronic; Models, Biolog | 1992 |
Adrenergic modulation of extrarenal potassium disposal in men with end-stage renal disease.
Topics: Adult; Epinephrine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Phentolamine; Potassium; Pro | 1991 |
Pharmacokinetics of misoprostol in the elderly, in patients with renal failure and when coadministered with NSAID or antipyrine, propranolol or diazepam.
Topics: Adult; Aged; Aging; Alprostadil; Anti-Inflammatory Agents, Non-Steroidal; Antipyrine; Diazepam; Drug | 1990 |
Effects of angiotensin converting enzyme inhibitors on the progression of renal failure and proteinuria in humans.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Captopril; Drug Therapy, Combination; Female; Furos | 1989 |
Beta-adrenergic-mediated extrarenal potassium disposal in patients with end-stage renal disease: effect of propranolol.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Drug Interactions; Epinephrine; Female; Humans; Hypokalemi | 1986 |
Tertatolol ameliorates renal function in rats with chronic renal failure.
Topics: Adrenergic beta-Antagonists; Animals; Electrolytes; Glomerular Filtration Rate; Kidney; Kidney Failu | 1988 |
Hypoglycemia in pediatric renal allograft recipients.
Topics: Child; Child, Preschool; Diuretics; Female; Follow-Up Studies; Graft Rejection; Humans; Hypoglycemia | 1988 |
Serum protein binding of phenytoin, diazepam and propranolol in chronic renal diseases.
Topics: Creatinine; Diazepam; Humans; Kidney Failure, Chronic; Nephrotic Syndrome; Orosomucoid; Phenytoin; P | 1987 |
Effect of propranolol on progression of chronic renal disease in partially nephrectomized rats.
Topics: Animals; Kidney Failure, Chronic; Kidney Function Tests; Male; Nephrectomy; Organ Size; Propranolol; | 1987 |
Renal haemodynamics during propranolol treatment in patients with arterial hypertension and chronic renal failure.
Topics: Adult; Female; Glomerular Filtration Rate; Humans; Hypertension; Kidney Failure, Chronic; Male; Midd | 1986 |
Action myoclonus-renal failure syndrome: a previously unrecognized neurological disorder unmasked by advances in nephrology.
Topics: Adult; Brain; Carbidopa; Electroencephalography; Electromyography; Female; Humans; Kidney Failure, C | 1986 |
Hyperkalemia complicating digoxin toxicity in a patient with renal failure.
Topics: Aged; Digoxin; Dose-Response Relationship, Drug; Humans; Hyperkalemia; Kidney Failure, Chronic; Male | 1985 |
Pharmacokinetics of oral propranolol in chronic renal disease.
Topics: Female; Half-Life; Hematocrit; Humans; Hypertension; Kidney Failure, Chronic; Male; Propranolol; Rad | 1974 |
Editorial: Frusemide.
Topics: Ethacrynic Acid; Furosemide; Hypertension; Kidney Failure, Chronic; Loop of Henle; Potassium; Propra | 1974 |
Malignant hypertension in children; a patient treated with bilateral nephrectomy.
Topics: Blood Pressure; Child; Creatinine; Female; Guanethidine; Humans; Hydralazine; Hydrochlorothiazide; H | 1974 |
Deterioration in renal function after beta-blockade in patients with chronic renal failure and hypertension.
Topics: Adult; Body Weight; Creatinine; Glomerulonephritis; Humans; Hypertension, Renal; Kidney; Kidney Fail | 1974 |
Propranolol in renal failure.
Topics: Adult; Female; Humans; Hypertension, Renal; Kidney Failure, Chronic; Male; Middle Aged; Propranolol | 1972 |